IU Simon Comprehensive Cancer Center published a recent article by Brijesh Patel, DO, and colleagues in Current Oncology.
Public source
Publisher name
Public post
Learn about the latest in cancer research from the cancer center’s Brijesh Patel, DO, and colleagues in their recent article published in Current Oncology. Read more: ht…
Company
IU Simon Comprehensive Cancer Center
The state's only NCI-designated comprehensive cancer center | A leader in cancer research
- Industry
- Research Services
- Location
- Indianapolis, US
- Company size
- 201–500 employees
About IU Simon Comprehensive Cancer Center
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center is Indiana’s only National Cancer Institute-designated comprehensive cancer center and a member of the National Comprehensive Cancer Network. Based at Indiana University, we focus on cancer research, education and clinical trials—not patient care. Our researchers and physician–scientists are discovering how cancer works, developing new therapies, and training the next generation of cancer researchers. While our healthcare partners provide treatment, we lead the research that fuels tomorrow’s cures.
See moreLatest activity
Latest activity from IU Simon Comprehensive Cancer Center
9 signals
Research & Knowledge
IU Simon Comprehensive Cancer Center contributed to an article published in the Journal of Cutaneous Pathology by Ahmed K. Alomari, MD, and colleagues.
Research & Knowledge
IU Simon Comprehensive Cancer Center published a new article in BJU International by Clinton D. Bahler, MD, and colleagues.
Research & Knowledge
IU Simon Comprehensive Cancer Center published a new article in Radiology titled Artificial Intelligence by Spyridon Bakas, PhD, and colleagues.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Cancer Research Foundation
Cancer Research Foundation supported the University of Chicago Medicine Comprehensive Cancer Center Dream Team update on pancreatic tumor lipid metabolism and resistance to treatment.
Research & Knowledge
Indiana University Foundation
Indiana University Foundation researchers Nabil Adra, MD, and Kirk Staschke, PhD, and Ronald Wek, PhD, are studying why targeted therapy benefits some patients but not others and identifying a potential way to cut off the amino acids prostate cancer cells depend on.
Research & Knowledge
Sarah Cannon Research Institute
Sarah Cannon Research Institute published findings from the UPBEAT study showing that depression and psychological stress made the biggest difference in whether survivors experienced fatigue up to two years after chemotherapy started.
Research & Knowledge
Break Through Cancer
Break Through Cancer published a study in PNAS by the Eradicating Measurable Residual Disease in AML TeamLab team developing a personalized blood test that tracks up to 96 mutations specific to an individual patient’s leukemia.
Research & Knowledge
The University of Illinois Cancer Center